Zum Hauptinhalt springen

Press Releases and Ad-hoc Announcements

06. November 2024
PR: Heidelberg Pharma: Promising New Clinical Data on Lead ADC-Candidate HDP-101 to be Presented at ASH Annual Meeting 2024
PDF
24. Oktober 2024
PR: Heidelberg Pharma to Participate in Leading Scientific and Financial Conferences in November 2024
PDF
10. Oktober 2024
PR: Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2024
PDF
01. Oktober 2024
PR: Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient
PDF
01. Oktober 2024
AH: Heidelberg Pharma AG Announces Updated Guidance
PDF
23. September 2024
PR: Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2024
PDF
11. Juli 2024
PR: Heidelberg Pharma Reports on First Half-Year 2024 and the Course of Business
PDF
21. Juni 2024
PR: Heidelberg Pharma reports on the results of the Annual General Meeting 2024
PDF
18. Juni 2024
AH: Heidelberg Pharma AG Announces Updated Guidance
PDF
23. Mai 2024
PR: Heidelberg Pharma to Participate and Present at Upcoming Leading Scientific Conferences in May and June 2024
PDF